Details Cookies
United Kingdom
Important margin product information

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 73% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs, FX or any of our other products work and whether you can afford to take the high risk of losing your money.

Cookie policy

This website uses cookies to offer you a better browsing experience by enabling, optimising and analysing site operations, as well as to provide personalised ad content and allow you to connect to social media. By choosing “Accept all” you consent to the use of cookies and the related processing of personal data. Select “Manage consent” to manage your consent preferences. You can change your preferences or retract your consent at any time via the cookie policy page. Please view our cookie policy here and our privacy policy here

A Reality Check in Store for Equities? A Reality Check in Store for Equities? A Reality Check in Store for Equities?

A Reality Check in Store for Equities?

Equities 5 minutes to read

Summary:  The reality of the ongoing deterioration in economic growth extending into the 4th quarter has yet to catch up with the Philadelphia Stock Exchange Semiconductor Index (SOX), up 39% YTD. Presenting a stark divergence with company outlooks and economic data.

Texas Instruments (TXN), the 2nd largest semiconductor company in the US and 1st to report this earnings cycle, have delivered a much weaker than expected forecast for the 4th quarter overnight. Taking the mid-point of the company’s projections TXN write down in revenue represents a 14% Y/Y decline in Q4. The company said that most of their end markets deteriorated over the quarter, reflecting the ongoing synchronised global slowdown, tech cycle downturn and the weight of the trade war. Previously TXN have stated cyclical downturns usually persist for 3 to 4 quarters but this is now the 4th consecutive quarter of declines with management guiding to an ongoing downturn. This is a representation of what we highlighted as the biggest test for equity markets as US companies report Q3 earnings. The moment of truth is coming as companies report a more sombre outlook into 2020 which is not in keeping with the consensus expectation of a recovery in FY2020 EPS growth which is one dynamic underpinning valuations and driving multiple expansion.

Macro data also continues to deteriorate and the 2H recovery touted earlier this year by some is ever elusive, last week’s China trade data was weak, imports and exports both fell by more than expected. Yesterday South Korean exports for the first 20 days of October posted a 20% decline from a year earlier so it looks like exports will contract for the 11th consecutive month once the month is out. South Korean data is typically a bellwether for global trade, giving a good read on the health of the global economy and global demand given that its industries are heavily integrated within the global supply chain and highly cyclical. It is for this reason that South Korean data is often used in global macro leading indicator models and expectations of future earnings growth and world trade growth, so this latest round of ugly trade data tempers any optimistic notion of a recovery in tech demand and global demand being around the corner. Coupled with TXN’s sobering outlook, the 39% YTD run up in the Philadelphia Stock Exchange Semiconductor Index (SOX) presents a stark divergence with economic realities, as we noted last month.

This is not unlike the present divergence from economic realities presented by the S&P 500 flirting, once again, with all time highs whilst data continue to deteriorate. When we cut through the noise of positive trade headlines to the economic data, the message is clear that the global economy continues to slow and the low point in growth remains ahead, not behind. On a trending basis the leading data is still deteriorating, and the direction of growth is still lower as we await hard data catch up to soft. We may be getting closer to approaching a cyclical turning point, but we do not have enough confidence or data to suggest that an imminent growth recovery is upon us. A growth stabilisation could occur next year, but we believe this is too early to position for, risks remain, and more stimulus will be needed along with confidence in improving fundamentals before positioning in pro-cyclical assets is warranted. Underneath the market surface, internals also remain weak. Whilst the S&P 500 is within 1.0% of another record high more than 47% of all individual stocks are below their respective 200-day averages.

The question then, is whether equities, relying on central banks to backstop markets and fulfil liquidity demands along with false trade optimism, can look through a period of weakness awaiting a cyclical upswing in growth momentum, or whether we have another shake out across equity markets. Lacklustre earnings outlooks and companies not being able to meet even the lowered bar on expectations could well be a catalyst for downside correction. Although this year, unlike last, the supportive policy response is already in play globally, so a corrective move is unlikely to be so severe.

On the positive front we have also seen a scaling back of some of the larger tail risks facing the global economy. A hard Brexit looks more and more likely to be avoided and the US and China are continuing to negotiate their way towards a partial deal. Although we don’t believe this mini deal will alter the relationship meaningfully and will only provide temporary relief from long-term bilateral tensions, the fact the two sides continue to engage is a positive. However, for the global economy, a pause on tariff hikes will not have a meaningful impact on growth and we still have the cycle to contend with. There is nothing on the horizon to suggest that already implemented tariffs will be rolled back anytime soon and tariff escalation is still a risk.

So as growth momentum continues to wane, we see no reason to avert from defensive positioning. Large enough upside catalysts are scarce so the present range bound nature of the S&P 500 is likely to remain status quo. It is difficult to see equities breaking significantly higher over next 3-6 months without a clear bottoming in global growth and the risk of recession taken off the table.


The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

Saxo Markets
40 Bank Street, 26th floor
E14 5DA
United Kingdom

Support Centre
For existing clients, please click here to request support via the Support Centre.

Have a question about our products, platforms or services? Visit the Support Centre to find answers for our most frequently asked questions. If you are still unable to locate an answer to your question, you will also find contact details for your local Saxo office to speak with a representative.

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo Markets is a registered Trading Name of Saxo Capital Markets UK Ltd (‘SCML’). SCML is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo Markets assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.